Loading...
Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer
BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) induce significant responses in EGFR-mutation positive non-small cell lung cancer (NSCLC). However, universal progression is observed. METHODS: The effect of the anti-rheumatoid agent, auranofin, a selective inhibi...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6835115/ https://ncbi.nlm.nih.gov/pubmed/31737502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.08.25 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|